MDxHealth SA Ordinary Shares (MDXH) Stock: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$0.21
0.02 (10.49%)
▲
5d:
-66.0%
30d:
-64.19%
90d:
-49.14%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDXH is down 66.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDXH is down 66.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $0.21, which is considered oversold relative to its 30-day fair value range of $0.40 to $0.70.
Technical Outlook: Technically, MDXH is showing sideways momentum. Immediate support is located at $0.17, while resistance sits at $0.68. The stock is showing strong short-term momentum, up 10.5% recently.
Market Sentiment: MDXH scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.83 (+287.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDXH is showing sideways momentum. Immediate support is located at $0.17, while resistance sits at $0.68. The stock is showing strong short-term momentum, up 10.5% recently.
Market Sentiment: MDXH scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.83 (+287.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.40 -
$0.70
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.5%)
- BULLISH: Trading 287.9% below Wall St target ($0.83)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.40 -
$0.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.17
Resistance Level
$0.68
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.57
Wall Street Target
$0.83
(+287.9%)
Revenue Growth (YoY)
2.3%
Profit Margin
-32.7%
Share & Embed Analysis
Last updated: October 21, 2026 9:28 PM ET
Data refreshes hourly during market hours. Next update: 10:28 PM
Data refreshes hourly during market hours. Next update: 10:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
